KD
Kevin DeGeeter Ladenburg Thalmann Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Oric Pharmaceuticals
ORIC
$1.06B
| $10.88 | $15 |
38%
upside
| Buy | 2 months ago |
|
2 |
2
NovoCure
NVCR
$1.37B
| $12.28 | $30 |
144%
upside
| Buy | 2 months ago |
|
3 |
3
Personalis
PSNL
$465M
| $5.24 | $24 |
358%
upside
| Outperform | 3 years ago |
|
4 |
4
NovoCure
NVCR
$1.37B
| $12.28 | $98 |
698%
upside
| Outperform | 3 years ago |
|
5 |
5
Fulgent Genetics
FLGT
$672M
| $21.95 | $125 |
469%
upside
| Outperform | 3 years ago |
|
6 |
6
Palo Alto Networks
PANW
$130B
| $194.46 | $79.17 |
59%
downside
| Outperform | 4 years ago |
|
7 |
7
Exact Sciences
EXAS
$10.2B
| $53.81 | $155 |
188%
upside
| Outperform | 4 years ago |
|
8 |
8
Rezolute
RZLT
$696M
| $8 | $25 |
213%
upside
| Outperform | 4 years ago |
|